An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Treatment Gaining Traction Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.
Thriving Commerce on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with thousands of participants share comparison images, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before directing customers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, physicians and chemists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users injecting products of uncertain source.
Some experts said the demand for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the British medical regulations.
Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or prison.
Platform Reaction and Content Elimination
According to TikTok, the service has removed problematic content and prohibited associated keywords and query recommendations. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Operations
Research also found communities with up to nine thousand members selling retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with images of weight loss, glowing testimonials and detailed guides for mixing or injecting at residence.
After minutes of entering one community, a seller shared WhatsApp details, where the majority of transactions occur. The vendor sent an guidebook and promised shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.
Item Information and Pricing
Inside these groups, messages show black plastic parcels with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When asked how long a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram stated it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they can’t verify. Although the science behind retatrutide is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her team has previously encountered individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to possibly serious health risks”.
